What is HOOKIPA Pharma?
Founded in 2011 and headquartered in New York City, HOOKIPA Pharma operates at the intersection of biotechnology and oncology. The company specializes in a unique class of immunotherapeutics that utilize arenavirus vectors to target virally mediated cancer antigens and self-antigens. By focusing on the body's innate ability to combat disease, HOOKIPA is carving out a distinct niche in the competitive landscape of cancer research. Their proprietary technology platform serves as the foundation for a robust pipeline, aiming to address unmet medical needs through innovative, science-led therapeutic interventions that move beyond traditional treatment modalities.
How much funding has HOOKIPA Pharma raised?
HOOKIPA Pharma has raised a total of $21.3M across 1 funding round:
Share Placement
$21.3M
Share Placement (2023): $21.3M with participation from Gilead Sciences
Key Investors in HOOKIPA Pharma
Gilead Sciences
A research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, with a strong focus on oncology and virology.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for HOOKIPA Pharma?
With the recent influx of capital, HOOKIPA Pharma is well-positioned to advance its clinical-stage programs through critical development milestones. The strategic focus will likely remain on scaling the manufacturing of its arenavirus-based candidates and expanding its immuno-oncology research initiatives. As the company navigates the complexities of clinical trials, the ongoing support from institutional partners will be instrumental in validating its therapeutic approach. Investors and industry analysts are closely monitoring the firm's progress, as successful data readouts could significantly enhance the company's valuation and solidify its standing as a leader in the next wave of cancer immunotherapy innovation.
See full HOOKIPA Pharma company page
